APA (7th ed.) Citation

Thom, G., Tian, M., Hatcher, J. P., Rodrigo, N., Burrell, M., Gurrell, I., . . . Gabathuler, R. (2019). A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. Journal of Cerebral Blood Flow & Metabolism, 39(10), 2074. https://doi.org/10.1177/0271678X18772998

Chicago Style (17th ed.) Citation

Thom, George, et al. "A Peptide Derived from Melanotransferrin Delivers a Protein-based Interleukin 1 Receptor Antagonist Across the BBB and Ameliorates Neuropathic Pain in a Preclinical Model." Journal of Cerebral Blood Flow & Metabolism 39, no. 10 (2019): 2074. https://doi.org/10.1177/0271678X18772998.

MLA (9th ed.) Citation

Thom, George, et al. "A Peptide Derived from Melanotransferrin Delivers a Protein-based Interleukin 1 Receptor Antagonist Across the BBB and Ameliorates Neuropathic Pain in a Preclinical Model." Journal of Cerebral Blood Flow & Metabolism, vol. 39, no. 10, 2019, p. 2074, https://doi.org/10.1177/0271678X18772998.